References
- Gnepp DR, Wenig BM. Surgical pathology of the salivary glands. WB Saunders, Philadelphia 1991; 350–68
- Seifert G. WHO international histological classification of tumours Histological typing of salivary gland tumours Berlin: Springer-Verlag, 2005:122–9.
- Gnepp DR. Malignant mixed tumors of the salivary glands. Pathol Ann 1993; 28: 279–328
- Castellini R, Vischer DW, Wykes S, Sarkar FH, Crissman JD. Interaction of transforming growth factor and epidermal growth factor receptor in breast carcinoma: an immunohistochemical study. Cancer 1994; 73: 344–9
- Wong CJW, Gallagher GJ, Gertz R, Chang AL, Shklar G. TGF-alpha in chemically transformed hamster oral keratinocytes. Cancer Res 1988; 48: 3130–4
- Grandes JR, Tweardy DJ. Elevated levels of transforming growth factor-alpha and epidermal growth factor receptor messenger RNA are early markers of carcinogenesis in head and neck cancer. Cancer Res 1993; 53: 3579–84
- Gerdes J, Lemke H, Baisch H, Wacker HH, Schwab U, Stein H. Cell cycle analysis of a cell proliferation associated human nuclear antigen defined by the monoclonal antibody Ki-67. J Immunol 1984; 133: 1710–15
- Katori H, Nozawa A, Tsukuda M. Markers of malignant transformation of sinonasal inverted papilloma. Eur J Surg Oncol 2005; 31: 905–11
- Srinivasan M, Jewell SD. Evaluation of TGF-alpha and EGFR expression in oral leukoplakia and oral submucous fibrosis by quantitative immunohistochemistry. Oncology 2001; 61: 284–92
- Hall PA, Hughes CM, Staddon SL, Richman PI, Gullick WJ, Lemoine NR. The c-erbB-2 proto-oncogene in human pancreatic cancer. J Pathol 1990; 161: 195–200
- Slamon DJ, GodophinW, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER-2/neu protooncogene in human breast and ovarian cancer Science 1989;244:707–16.
- Ro J, El-Naggar AK, Ro JY, Blick M, Frye D, Fraschini G, et al. c-erbB-2 amplification in node negative breast cancer. Cancer Res 1989; 49: 6941–4
- Press MF, Pike MC, Hung G, Zhou JY, Ma Y, George J, et al. Amplification and overexpression of HER-2/neu in carcinomas of the salivary gland: correlation with poor prognosis. Cancer Res 1994; 54: 5675–82
- Kernohan NM, Blessing K, King G, Corbett IP, Miller ID. Expression of c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study. J Pathol 1991; 163: 77–80
- Sugano S, Mukai K, Tsuda H, Hirohashi S, Furuya S, Shimosato Y, et al. Immunohistochemical study of c-erbB-2 oncoprotein overexpression in human major salivary gland carcinoma: an indicator of aggressiveness. Laryngoscope 1992; 102: 923–7
- Karja V, Syrjanen S, Kataja V, Syrjanen K. c-erbB-2 oncogene expression in salivary gland tumours. ORL J Otorhinolaryngol Relat Spec 1994; 56: 206–12
- Shrestha P, Huang JW, Tsuji T, Shinozaki F, Maeda K, Sasaki K, et al. Rare expression of the c-erbB-2 oncoprotein in salivary gland tumours: an immunohistochemical study. J Oral Pathol Med 1992; 21: 477–80
- Booster J, De Last SW, Ponec M. Epidermal growth factor receptor expression related to differentiation capacity in normal and transformed keratinocytes. Exp Cell Res 1985; 161: 421–33
- Stoscheck CM, King LE. Role of epidermal growth factor in carcinogenesis. Cancer Res 1986; 46: 1030–7
- Cutry AF, Kinniburgh AJ, Krabak MJ, Hui SW, Wenner CE. Induction of c-fos and c-myc proto-oncogene expression by epidermal growth factor and transforming growth factor-alpha is calcium independent. J Biol Chem 1989; 264: 19700–75
- Miyaguchi M, Olfsson J, Hellquist HB. Immunohistochemical study of epidermal growth factor receptor in severe dysplasia and carcinoma in situ of vocal cords. Acta Otolaryngol (Stockh) 1991; 11: 149–52
- Filipe MI, Osborn M, Linehan J, Sanidas E, Brito MJ, Jankowski J. Expression of transforming growth factor-alpha, and epidermal growth factor receptor in precursor lesions to gastric carcinoma. Br J Cancer 1995; 71: 30–6